PAVMED INC. (NASDAQ:PAVM) Files An 8-K Unregistered Sales of Equity Securities

Item 3.02Unregistered Sales of Equity Securities.

In accordance with the Purchase Agreement which was disclosed in
the Current Report on Form 8-K which PAVmed Inc. (the
Corporation) filed with the U.S. Securities and Exchange
Commission on February 1, 2017, the Corporation issued under such
Purchase Agreement an additional 171,504 Units at a price of
$6.00 per Unit. Each Unit consists of one share of Series A
Convertible Preferred Stock and one Series A Warrant exercisable
for one share of common stock. Each Series A Warrant is
exchangeable for four Series X Warrants, each of which is
exercisable for one share of common stock. A further description
of the Series A Convertible Preferred Stock, the Series A
Warrants and the Series X Warrants, including the terms of
conversion and exercise, is set forth in the aforesaid Form 8-K.

On March 8, 2017, the Corporation received aggregate cash gross
proceeds of $1,029,012 in connection with the sale of the Units.
The Corporation paid commissions of $72,019.68 in connection with
the sale of the Units, resulting in net proceeds to the
Corporation, before payment of any expenses, of $956,992.32.

The Units were offered and sold in a private placement to
exemptions from the registration requirements of the Securities
Act under Section 4(a)(2) thereof and Rule 506 of Regulation D
promulgated thereunder.

Item 9.01Financial Statements and Exhibits

(d) Exhibits

PAVMED INC. (NASDAQ:PAVM) Recent Trading Information

PAVMED INC. (NASDAQ:PAVM) closed its last trading session up +0.98 at 6.10 with 4,830 shares trading hands.